What is Tirzepatide?

We use a compounded version of Tirzepatide sourced from reputable FDA-regulated Pharmacies  to ensure safety and quality. The brand name version of Tirzepatide is an injectable medication initially released in 2022 as a treatment for Type 2 Diabetes. Later under a different brand name, a new version was approved in 2023 for use as a weight management medication that is administered via weekly injections. Tirzepatide operates through a distinctive dual-action mechanism targeting two pivotal hormones to regulate blood sugar and supress appetite: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). As a dual GIP and GLP-1 receptor agonist, it helps the body’s natural response to these hormones. GLP-1 aids in reducing blood glucose levels by promoting insulin release in response to elevated blood sugar, slowing gastric emptying, and curbing appetite, thus promoting weight loss. The GIP element enhances this effect by further improving insulin sensitivity and potentially boosting the body’s capacity to utilize fat reserves for energy.

​

Who is a candidate?

If you have a  BMI of 27 and struggle to maintain a healthy weight due to overeating or an uncontrollable appetite, and experiencing weight-related health issues (elevated cholesterol, pre-diabetes, high blood pressure, high visceral fat, PCOS), is a good candidate. If your BMI is 30+, you do not need a weight related medical problem.

 

You are NOT a good candidate for Tirzepatide if you have any of the following: diabetic retinopathy, low blood sugar, decreased kidney function, pancreatitis, gallbladdrer disease, a history of severe gastrointestinal disease, medullary thyroid cancer (MTC) or a family history of MTC, or multiple endocrine neoplasia syndrome type 2 (MTC). Breastfeeding or those who are pregnant or trying to conceive/start/or add to their family in the next 3 months (both men and women) should avoid taking this medication.

​

What are the side effects?

Tirzepatide injections are generally well-tolerated, but they might also come with several side effects due to your body’s reaction to the medications. Mild to moderate adverse reactions that usually resolve within 2 weeks include:

• Nausea

• Vomiting

• Diarrhea

• Constipation

• Heartburn

• Belching/burping

• Abdominal pain

• Headache

• Fatigue

• Dizziness

 

Some rare adverse effects are:​

• Hives

• Swelling lips, tongue, throat

• Dehydration

• Gallbladder problems (severe stomach pain, vomiting and fever)

• Kidney injury (decrease in urine, swelling of ankles, hands, feet)

 

Our medical professionals will ensure to keep in touch with you and check you up for any side effects. This ensures a safe and smooth weight management treatment, promoting overall health.

​

How much weight can I lose?

In clinical trials, the brand name version of Tirzepatide approved for weight management helped most people with obesity lose on average 15% to 20% of their starting body weight over 72 weeks. 

​

 

Book your consultation to discuss your concerns.

**Cost of consultation will be applied to your future treatment**